Talking Medicines
Talking Medicines is a data intelligence company specializing in healthcare marketing. They offer AI-powered solutions like Drug-GPT to extract actionable insights from healthcare conversational data, helping healthcare agencies and pharmaceutical companies enhance their marketing strategies and improve patient outcomes. Their focus on advanced data science and AI positions them as a leader in the healthcare data intelligence sector.
Headcount
Website visitors
Workforce
Headcount by location
- United Kingdom85%
- United States7.7%
- Spain7.7%
Split by department
- Engineering & R&D21%
- Founder, Owner & Executive16%
- Consulting & Advisory11%
- Marketing & Comms11%
- Customer Support5.3%
Seniority distribution
- Less than 5 years37%
- 10 to 20 years26%
- 5 to 10 years26%
- 20 to 30 years5.3%
- 30 years and more5.3%
Funding
Raised to date
- 28 Jul 2026Convertible Note$0.1MTern PLC - we back growing IoT companies
- 26 May 2026Convertible Note$0.3MTern PLC - we back growing IoT companies
6 earlier rounds, with their terms and sources.
Investors
Scottish EnterpriseScottish Enterprise is a not-for-profit economic development agency that supports businesses in Scotland by providing strategic guidance, funding access, and market insights. It focuses on helping companies innovate and scale, particularly in3,900United Kingdom
Tern PLC - we back growing IoT companiesTern PLC is an investment company that focuses on empowering technology firms, particularly those involved in disruptive innovations and the Internet of Things. It provides investment and advisory services to help startups navigate market challenges11United Kingdom
EnteroBiotixEnteroBiotix is a biotechnology company specializing in microbiome therapeutics aimed at improving gut health. They develop innovative treatments for gastrointestinal disorders, focusing on products like EBX-102-02. Their customers include patients4United Kingdom
TERN AustraliaTERN is a not-for-profit organization dedicated to ecosystem research and monitoring in Australia. It provides essential data and infrastructure to researchers and land managers, facilitating the understanding of environmental changes and climate2Australia
Revenue
EBITDA
Revenue source: Modeled estimate
Recent news
- Tern portfolio company Talking Medicines launches 'Intent to Prescribe' DrugVoice application.
- AIM movers: Sound Energy sells Moroccan assets.
8 more articles, with their sources and categories.
People
How the team has changed month by month — joiners, leavers and where the hiring is going
Connections
Who at your firm already knows someone here, and how warm the path is
The full Talking Medicines profile lives in Inven.
Your competitors are already on Inven
See how Inven turns hours of manual research into a single, structured workflow.